Burden, Mortality and Supply Costs in Intensive Care Unit Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Ulm

About this trial

This study systematically observes in a pragmatic trail under real world conditions the association between strategies of therapy (maximal therapy, withhold, withdraw) and treatment success in three endpoint related initial risk groups (high, intermediate, low risk) regarding three endpoints (burden, mortality and supply costs).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All patients dying on the ICU and all patients staying for at least 72 hours on the ICU

Disqualifiers

No

Trial population

Critically ill patients admitted to the intensive care unit, mainly surgical and polytraumatized patients

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

700 Participants
are grouped into 1 trial group
Group A: Intensive care unit patient

Trial outcomes

Primary outcomes

1

Burden of care

Organ dysfunctions supported or replaced in numbers

Time frame
18 months
2

Mortality

Dying patients in numbers

Time frame
18 months
3

Supply costs

Costs in sum of Simplified Acute Physiology Score (SAPS) II score points over ICU stay; Costs in sum of points of organ support over ICU stay; Costs in Euro reimbursed for the ICU stay

Time frame
18 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.